Your browser doesn't support javascript.
A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project.
Molino, Diana; Durier, Christine; Radenne, Anne; Desaint, Corinne; Ropers, Jacques; Courcier, Soizic; Vieillard, Louis Victorien; Rekacewicz, Claire; Parfait, Beatrice; Appay, Victor; Batteux, Frédéric; Barillot, Emmanuel; Cogné, Michel; Combadière, Béhazine; Eberhardt, Christiane S; Gorochov, Guy; Hupé, Philippe; Ninove, Laetitia; Paul, Stéphane; Pellegrin, Isabelle; van der Werf, Sylvie; Lefebvre, Maeva; Botelho-Nevers, Elisabeth; Ortega-Perez, Inmaculada; Jaspard, Marie; Sow, Samba; Lelièvre, Jean Daniel; de Lamballerie, Xavier; Kieny, Marie Paule; Tartour, Eric; Launay, Odile.
  • Molino D; Université Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
  • Durier C; INSERM SC10-US019, Villejuif, France.
  • Radenne A; AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière, Paris, France.
  • Desaint C; INSERM SC10-US019, Villejuif, France.
  • Ropers J; AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière, Paris, France.
  • Courcier S; Université Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
  • Vieillard LV; Université Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
  • Rekacewicz C; Université Paris Cité, National Institute for Health and Medical Research (INSERM) CIC 1417 Cochin Pasteur, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
  • Parfait B; AP-HP, Hôpital Cochin, Fédération des Centres de Ressources Biologiques-Plateforme de Ressources Biologiques Centre de Ressources Biologique Cochin, Paris, France.
  • Appay V; Centre Hospitalier Universitaire (CHU) Bordeaux, Laboratory of Immunology and Immunogenetics, Université de Bordeaux, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, France.
  • Batteux F; AP-HP, Hôpital Cochin, Service d'Immunologie Biologique et Plateforme d'Immunomonitoring Vaccinal, Paris, France.
  • Barillot E; Institut Curie, PSL Research University-INSERM U900-MINES ParisTech, PSL, Paris, France.
  • Cogné M; Laboratory of Immunology-Research Unit INSERM U 1236, B cell Ig Remodelling Singularities (BIGRES), Faculty of Medicine, French Blood Center (EFS Bretagne) & University Hospital, Rennes, France.
  • Combadière B; Centre d'Immunologie et des Maladies Infectieuses-Paris (Cimi-Paris), INSERM U1135, Sorbonne Université, Paris, France.
  • Eberhardt CS; University of Geneva, Faculty of Medicine, Division of General Pediatrics, Department of Woman, Child and Adolescent Medicine and Center for Vaccinology, Geneva, Switzerland.
  • Gorochov G; Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Département d'Immunologie, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Hupé P; Institut Curie, PSL Research University-INSERM U900-MINES ParisTech, PSL, Paris, France.
  • Ninove L; CNRS, UMR 144, Paris, France.
  • Paul S; Aix Marseille Université, Research Institute for Sustainable Development (IRD) 190, INSERM 1207, IHU Méditerranée Infection, Unité des Virus Émergents, Marseille, France.
  • Pellegrin I; INSERM, U1111, CNRS, UMR 530, Immunology and Immunomonitoring Laboratory, iBiothera, CIRI-GIMAP, UCBL 1, UJM, CIC 1408, Saint-Etienne, France.
  • van der Werf S; Centre Hospitalier Universitaire (CHU) Bordeaux, Laboratory of Immunology and Immunogenetics, Université de Bordeaux, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, France.
  • Lefebvre M; Université Paris Cité, Institut Pasteur, Unité Génétique Moléculaire Virus à ARN UMR 3569 CNRS, Paris, France.
  • Botelho-Nevers E; CHU de Nantes, INSERM CIC1413, Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles, Nantes, France.
  • Ortega-Perez I; INSERM CIC 1408, Axe Vaccinologie, CHU de Saint-Etienne, Service d'Infectiologie, Saint-Etienne, France.
  • Jaspard M; ANRS | Emerging Infectious Diseases, Paris, France.
  • Sow S; The Alliance for International Medical Action (ALIMA), Paris, France.
  • Lelièvre JD; University of Bordeaux, INSERM, IRD, Bordeaux Population Health Center, UMR 1219, Bordeaux, France.
  • de Lamballerie X; The Center for Vaccine Development, Bamako, Mali.
  • Kieny MP; INSERM U955, Créteil, France, Vaccine research Institute, Créteil, France.
  • Tartour E; Aix Marseille Université, Research Institute for Sustainable Development (IRD) 190, INSERM 1207, IHU Méditerranée Infection, Unité des Virus Émergents, Marseille, France.
  • Launay O; INSERM 101, Paris, France.
Nat Med ; 28(5): 882-884, 2022 05.
Article in English | MEDLINE | ID: covidwho-1830082

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2022 Document Type: Article Affiliation country: S41591-022-01785-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2022 Document Type: Article Affiliation country: S41591-022-01785-4